Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-analysis of Randomized Controlled Trials
ARP Rheumatology · 2025
DOI: 10.63032/hyau2255 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ARP Rheumatology, 2025. Verfasst von Brijesh Baral und 5 weiteren Autor:innen. Beteiligte Einrichtung: Birat Medical College and Teaching Hospital. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Birat Medical College and Teaching Hospital.
- CES University, School of Medicine.
- Universidade Estácio de Sá - IDOMED.
- Brandeis University.
- UABC Research Coordination.
Zitieren
APA
Baral, B., Parajuli, M., Pinilla, J., Quintanilha, B., Baral, B., & Molina, F. C. (2025). Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ARP Rheumatology. https://doi.org/10.63032/hyau2255
Vancouver
Baral B, Parajuli M, Pinilla J, Quintanilha B, Baral B, Molina FC. Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ARP Rheumatology. 2025. doi:10.63032/hyau2255
BibTeX
@article{Baral2025,
author = {Baral, Brijesh and Parajuli, Mandakini and Pinilla, Juan and Quintanilha, Beatriz and Baral, Bishal and Molina, Fidencio Cons},
title = {Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-analysis of Randomized Controlled Trials},
journal = {ARP Rheumatology},
year = {2025},
doi = {10.63032/hyau2255}
}
EUVIMED